Translation and Validation of the COMM and ASI-SR
NCT06084520
Alcohol Use Disorder, Alcohol-Related Disorders
Uppsala, Uppland, Sweden
View Trial DetailsNCT Number: NCT06350409
The goal of this observational study is to examine the factors associated with the transition from medical exposure to opioids with "signposts" of future opioid use disorder among adolescent surgical patients. The main question aims to identify factors (moderators, mediators, and covariates) associated with risk factors for opioid use disorder (ROUD) in the 12 months following major surgery with opioid exposure among adolescents aged 12-17. Participants will be asked to complete electronic surveys pre- and post-operatively and approve the collection of peri-operative data from the Electronic Medical Record to assess correlations.
Interested in participating?
Request Info12 year–17 year
All sexes
Observational
Children's Hospital Colorado, Aurora, Colorado, United States
This project will collect data from a diverse sample of 10,000 dyads, including adolescent (aged 12-17 years, inclusive) patients undergoing major surgery with planned post-operative opioid analgesic use. and a parent (Total N=20,000) to identify ROUD that may occur within the 12 months after surgery. The resulting data repository will allow clinician scientists and physicians to develop research-informed pain management protocols for adolescent surgical patients to reduce the risk of OUD in this vulnerable population.
Using a novel combination of data sources (electronic medical records (EMR), patient-reported outcomes, and parent-reported outcomes), this study investigates the twin problems of postoperative pain and ROUD in adolescent surgical patients. Using real-world evidence to evaluate longitudinal behaviors and outcomes.
This project will provide insights into the associations between post-operative pain management and ROUD in adolescents. Findings could yield information about potential risks, which may inform future studies and ultimately lead to new screening tools to assess risk before opioid prescribing, updated protocols for managing pain intra-operatively and post-operatively in high-risk populations, updated patient and family education materials to reduce risks for those undergoing painful procedures, and revised recommendations for monitoring for patients being treated for pain. Furthermore, the project enables the establishment of an infrastructure among pediatric surgical centers that can be used for future projects to evaluate the best postoperative outcomes for youth.
Aim 1: Determine the frequency of ROUD. Because this is a novel measure of ROUD, we will use the first 1,000 samples to estimate the incidence of ROUD developing among adolescents in the year following surgery with post-operative opioid analgesia.
Aim 2: We will use machine learning models to develop and validate screening algorithms designed to detect "early warning signs" or Risk factors for Opioid Use Disorder (ROUD). The features in these models will include the pre-, intra- and postoperative EMR-derived data elements, as well as the survey data. We will fit the models against the primary outcome described above. Model evaluation will be done via cross-validation, where the models will be fit on a randomly selected training set of patients and evaluated on the remaining held-out subset of the patients to be used exclusively for testing the performance of the final models.
Aim 3: Developing and validating a prediction model designed to predict a clinical trajectory of post-surgical opioid use and pain. We will use clustering to identify typical patient trajectories of opioid use, and we will use similar prediction and validation techniques as in Aim 1 to build a prediction model for these trajectories.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Adolescent Inclusion Criteria
Parent/Caregiver Inclusion Criteria
Adolescent Exclusion Criteria
Adolescents meeting any of the following criteria will be excluded from study participation:
Parent/Caregiver Exclusion Criteria
Parents/Caregivers meeting any of the following criteria will be excluded from study participation:
Time frame: 12 months
The patient self-report an average pain score of more than 3/10 in the last 7 days on the Brief Pain Inventory (BPI) at 3 or more months postoperatively.
Time frame: 12 months
Any adolescent self-report or parent report of opioid medication use more than 3 or more months postoperatively.
Time frame: 12 monhts
Any adolescent self-report or parent report of use of opioid medication that is > than prescribed, or more frequently than prescribed, or not prescribed to the adolescent.
Time frame: 12 month
Adolescent self-report of rate of increase of substance use frequency greater than the 75th percentile of an age- and sex-matched cohort compared to nationally representative data
Time frame: 12 months
Adolescent self-report of post-surgical trauma and stress as measured by >11 on the Child PTSD Symptom Scale (CPSS) 3 or more months postoperatively.
Contact information is provided by the study sponsor or research team.
Joesph Cravero, MD
CONTACT
Sharon Levy, MD, MPH
CONTACT
Sharon Levy
Other
Acronym: APEX
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06084520
Alcohol Use Disorder, Alcohol-Related Disorders
Uppsala, Uppland, Sweden
View Trial DetailsNCT06028126
Anesthesia, Local, Chemically-Induced Disorders
Calgary, Alberta, Canada
View Trial DetailsNCT07693270
Chemically-Induced Disorders, Mental Disorders
La Jolla, California, United States
View Trial DetailsNCT06544291
Chemically-Induced Disorders, Chronic Pain
New Haven, Connecticut, United States
View Trial Details